SPTX
Seaport Therapeutics Inc
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2026-05-01
$20.20
+0.19 (+0.95%)
last quote
Want the full multi-source brief on SPTX?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$20.20
High
$20.56
Low
$19.51
Previous close
$20.01
Fundamentals
Market cap
$1.07B
P/E (TTM)
—
P/S (TTM)
—
P/B
—
Gross margin
—
Operating margin
—
Net margin
—
Rev growth (YoY)
—
EPS growth (YoY)
—
ROE
—
52W high
$28.38
52W low
$14.85
Beta
0.48x
Recent SEC filings
CIK 2042347filing-language history →
Recent news
2026-10-28 → 2026-11-04
Yahoo · 2d
Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
BOSTON, November 02, 2026--Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Benzinga · 2d
Seaport Therapeutics Q3 EPS $(0.49) Beats $(0.58) Estimate
Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.58) by 15.52 percent. This is a 94.8 percent increase over losses of $(9.43) per share
SeekingAlpha · 6d
Seaport Therapeutics: Borrowed Efficacy, Engineered Safety, And A Post-IPO Discount
Yahoo · 7d
Seaport Therapeutics to Present at Stifel 2026 Healthcare Conference
BOSTON, October 28, 2026--Seaport Therapeutics to Present at Stifel 2026 Healthcare Conference
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial